ATE450865T1 - Zusammensetzungen mit kontrollierter freigabe enthaltend nimesulid - Google Patents
Zusammensetzungen mit kontrollierter freigabe enthaltend nimesulidInfo
- Publication number
- ATE450865T1 ATE450865T1 AT00992052T AT00992052T ATE450865T1 AT E450865 T1 ATE450865 T1 AT E450865T1 AT 00992052 T AT00992052 T AT 00992052T AT 00992052 T AT00992052 T AT 00992052T AT E450865 T1 ATE450865 T1 AT E450865T1
- Authority
- AT
- Austria
- Prior art keywords
- controlled release
- compositions containing
- release compositions
- containing nimesulide
- nimesulide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1297DE1999 | 1999-09-28 | ||
| PCT/IN2000/000094 WO2001022791A2 (en) | 1999-09-28 | 2000-09-27 | Controlled release compositions comprising nimesulide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE450865T1 true ATE450865T1 (de) | 2009-12-15 |
Family
ID=11092667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00992052T ATE450865T1 (de) | 1999-09-28 | 2000-09-27 | Zusammensetzungen mit kontrollierter freigabe enthaltend nimesulid |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US20070128276A1 (de) |
| EP (1) | EP1218889B1 (de) |
| JP (2) | JP4359412B2 (de) |
| KR (1) | KR100621281B1 (de) |
| CN (2) | CN1399543A (de) |
| AP (1) | AP1954A (de) |
| AT (1) | ATE450865T1 (de) |
| AU (1) | AU774099B2 (de) |
| BG (1) | BG66093B1 (de) |
| BR (1) | BR0014383A (de) |
| CA (1) | CA2385890C (de) |
| CZ (1) | CZ20021076A3 (de) |
| DE (1) | DE60043447D1 (de) |
| DK (1) | DK1218889T3 (de) |
| ES (1) | ES2337547T3 (de) |
| HU (1) | HUP0204451A3 (de) |
| IL (2) | IL148864A0 (de) |
| MX (1) | MXPA02003321A (de) |
| NO (1) | NO20021540L (de) |
| NZ (1) | NZ518052A (de) |
| PT (1) | PT1218889E (de) |
| RS (1) | RS50303B (de) |
| RU (1) | RU2238087C2 (de) |
| UA (1) | UA80667C2 (de) |
| WO (1) | WO2001022791A2 (de) |
| ZA (1) | ZA200202411B (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003303744A1 (en) * | 2003-10-31 | 2005-06-17 | Elan Pharma International Ltd. | Novel nimesulide compositions |
| EP1750717B1 (de) * | 2004-02-11 | 2017-07-19 | Rubicon Research Private Limited | Pharmazeutische zusammensetzungen mit kontrollierter freisetzung und verbesserter bioverfügbarkeit |
| ES2540929T3 (es) * | 2005-02-01 | 2015-07-14 | Emisphere Technologies, Inc. | Sistema de administración de retención gástrica y liberación controlada |
| CN101227893A (zh) * | 2005-07-20 | 2008-07-23 | 万能药生物有限公司 | 新型药物控释剂型环加氧酶抑制剂 |
| CN100346778C (zh) * | 2005-07-22 | 2007-11-07 | 海南康力元药业有限公司 | 尼美舒利缓释组合物 |
| RS20080497A (en) * | 2006-04-24 | 2009-05-06 | Panacea Biotec Ltd., | Novel low dose pharmaceutical compositions comrising nimesulide, preparation and use thereof |
| MX2009013384A (es) * | 2007-06-08 | 2010-01-25 | Addrenex Pharmaceuticals Inc | Formulacion de liberacion extendida, y metodo para tratar disregulacion adrenergica. |
| BE1018280A3 (fr) * | 2008-09-09 | 2010-08-03 | Squarepoint Pointcarre Sprl | Composition de nimesulide a liberation prolongee. |
| EP2346351B1 (de) * | 2008-09-22 | 2019-07-03 | Rubicon Research Private Limited | Zusammensetzungen mit verzögertem durchgang durch den magen-darm-trakt |
| EP2403487A2 (de) * | 2009-03-04 | 2012-01-11 | Fdc Limited | Orale darreichungsformen mit verzögerter freisetzung für wasserlösliche arzneimittel |
| WO2010138441A1 (en) * | 2009-05-28 | 2010-12-02 | Aptapharma, Inc. | Multilayer oral tablets containing a non-steroidal anti-inflammatory drug and/or acetaminophen |
| US8513259B2 (en) | 2009-07-03 | 2013-08-20 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
| US8263581B2 (en) | 2009-07-03 | 2012-09-11 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
| CN102188386B (zh) * | 2010-03-02 | 2013-09-04 | 海南葫芦娃制药有限公司 | 尼美舒利缓释微丸及其制备方法 |
| CN102232928A (zh) * | 2010-04-20 | 2011-11-09 | 广州艾格生物科技有限公司 | 一种尼美舒利缓释干混悬剂及其制备方法 |
| US20120010216A1 (en) * | 2010-07-06 | 2012-01-12 | Brown Arthur M | Pharmaceutical compositions containing vanoxerine |
| CN102485220A (zh) * | 2010-12-03 | 2012-06-06 | 沈阳药科大学 | 尼美舒利单层渗透泵控释片 |
| WO2012159077A2 (en) * | 2011-05-18 | 2012-11-22 | Board Of Regents, The University Of Texas System | Multiple dosing regimen oral drug delivery platform |
| CN103142565B (zh) * | 2012-04-18 | 2015-04-29 | 中国人民解放军军事医学科学院毒物药物研究所 | 一种尼美舒利的缓释药物组合物及其制备方法 |
| AU2015217073B2 (en) | 2014-02-13 | 2019-08-22 | Incyte Holdings Corporation | Cyclopropylamines as LSD1 inhibitors |
| HUE045725T2 (hu) | 2014-02-13 | 2020-01-28 | Incyte Corp | Ciklopropilaminok mint LSD1 inhibitorok |
| US20150275167A1 (en) * | 2014-03-28 | 2015-10-01 | Corning Incorporated | Composition and method for cell culture sustained release |
| WO2016007722A1 (en) | 2014-07-10 | 2016-01-14 | Incyte Corporation | Triazolopyridines and triazolopyrazines as lsd1 inhibitors |
| CN105435239B (zh) * | 2014-08-29 | 2019-04-26 | 武汉光谷人福生物医药有限公司 | 美索舒利薄膜衣片及其制备方法 |
| TWI714567B (zh) | 2015-04-03 | 2021-01-01 | 美商英塞特公司 | 作為lsd1抑制劑之雜環化合物 |
| RU2017141029A (ru) * | 2015-05-25 | 2019-06-25 | Сан Фармасьютикал Индастриз Лимитед | Фармацевтическая пероральная композиция изотретиноина для применения один раз в сутки |
| MY189367A (en) | 2015-08-12 | 2022-02-08 | Incyte Corp | Salts of an lsd1 inhibitor |
| US9675585B1 (en) | 2016-03-24 | 2017-06-13 | Ezra Pharma | Extended release pharmaceutical formulations |
| US9687475B1 (en) | 2016-03-24 | 2017-06-27 | Ezra Pharma Llc | Extended release pharmaceutical formulations with controlled impurity levels |
| WO2018190621A1 (ko) * | 2017-04-10 | 2018-10-18 | 성균관대학교 산학협력단 | 다공성 위체류층을 포함하는 서방성 제제 및 이의 제조방법 |
| US10968200B2 (en) | 2018-08-31 | 2021-04-06 | Incyte Corporation | Salts of an LSD1 inhibitor and processes for preparing the same |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4424235A (en) * | 1981-09-14 | 1984-01-03 | Hoffmann-La Roche Inc. | Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor |
| US4666928A (en) * | 1984-08-30 | 1987-05-19 | Merck Frosst Canada, Ind. | Propylphenoxy pyridine carboxylates as leukotriene antagonists |
| IT1215726B (it) * | 1988-01-18 | 1990-02-22 | Alfa Wassermann Spa | Formulazioni galeniche a cessione programmata. |
| IN187379B (de) * | 1996-04-12 | 2002-04-13 | Panacea Biotec Ltd | |
| ATE394107T1 (de) * | 1996-05-23 | 2008-05-15 | Novartis Pharma Gmbh | Vorbeugung und behandlung von kolonadenom oder kolonmikroadenom mit 6-fluorursodeoxycholsäure |
| IN186315B (de) * | 1996-12-12 | 2001-08-04 | Panacea Biotec Ltd | |
| ES2129010B1 (es) * | 1997-01-02 | 2000-01-16 | Gold Oscar | Composicion de accion prolongada en granulos que contienen 4-nitro-2- fenoximetansulfonanilida y su procedimiento de preparacion. |
| US5948787A (en) * | 1997-02-28 | 1999-09-07 | Alza Corporation | Compositions containing opiate analgesics |
| CN1277550A (zh) * | 1997-09-11 | 2000-12-20 | 尼科梅德丹麦有限公司 | 非甾体抗炎药物(NSAIDs)的改进释放的复合型组合物 |
| IN188720B (de) * | 1997-11-06 | 2002-11-02 | Panacea Biotec Ltd | |
| FR2772615B1 (fr) * | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
| US6184220B1 (en) * | 1998-03-27 | 2001-02-06 | Boehringer Ingelheim Pharma Kg | Oral suspension of pharmaceutical substance |
| BR9804993A (pt) * | 1998-11-10 | 2000-06-06 | Panacea Biotec Ltd | Composição antialérgica e antiinflamatória |
-
2000
- 2000-09-27 WO PCT/IN2000/000094 patent/WO2001022791A2/en not_active Application Discontinuation
- 2000-09-27 KR KR1020027003996A patent/KR100621281B1/ko not_active IP Right Cessation
- 2000-09-27 AP APAP/P/2002/002450A patent/AP1954A/en active
- 2000-09-27 HU HU0204451A patent/HUP0204451A3/hu unknown
- 2000-09-27 DK DK00992052.1T patent/DK1218889T3/da active
- 2000-09-27 RU RU2002111365/15A patent/RU2238087C2/ru not_active IP Right Cessation
- 2000-09-27 JP JP2001526021A patent/JP4359412B2/ja not_active Expired - Fee Related
- 2000-09-27 NZ NZ518052A patent/NZ518052A/en not_active IP Right Cessation
- 2000-09-27 DE DE60043447T patent/DE60043447D1/de not_active Expired - Lifetime
- 2000-09-27 RS YUP-234/02A patent/RS50303B/sr unknown
- 2000-09-27 AU AU28799/01A patent/AU774099B2/en not_active Ceased
- 2000-09-27 CZ CZ20021076A patent/CZ20021076A3/cs unknown
- 2000-09-27 UA UA2002032356A patent/UA80667C2/uk unknown
- 2000-09-27 CA CA002385890A patent/CA2385890C/en not_active Expired - Fee Related
- 2000-09-27 AT AT00992052T patent/ATE450865T1/de active
- 2000-09-27 BR BR0014383-9A patent/BR0014383A/pt not_active IP Right Cessation
- 2000-09-27 CN CN00814424A patent/CN1399543A/zh active Pending
- 2000-09-27 MX MXPA02003321A patent/MXPA02003321A/es active IP Right Grant
- 2000-09-27 IL IL14886400A patent/IL148864A0/xx active IP Right Grant
- 2000-09-27 CN CN200910159790A patent/CN101804041A/zh active Pending
- 2000-09-27 EP EP00992052A patent/EP1218889B1/de not_active Expired - Lifetime
- 2000-09-27 ES ES00992052T patent/ES2337547T3/es not_active Expired - Lifetime
- 2000-09-27 PT PT00992052T patent/PT1218889E/pt unknown
-
2002
- 2002-03-25 IL IL148864A patent/IL148864A/en unknown
- 2002-03-26 ZA ZA200202411A patent/ZA200202411B/en unknown
- 2002-03-27 NO NO20021540A patent/NO20021540L/no not_active Application Discontinuation
- 2002-04-11 BG BG106605A patent/BG66093B1/bg unknown
-
2006
- 2006-10-10 US US11/545,718 patent/US20070128276A1/en not_active Abandoned
-
2007
- 2007-06-01 JP JP2007147523A patent/JP2007217436A/ja active Pending
- 2007-10-26 US US11/978,162 patent/US20080160082A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE450865T1 (de) | Zusammensetzungen mit kontrollierter freigabe enthaltend nimesulid | |
| ATE252386T1 (de) | Galantamin-zusammensetzung mit gesteuerter freisetzung | |
| IS6120A (is) | Lyfjablanda | |
| ATE441404T1 (de) | Orale dosiszusammensetzung mit verlängerter freigabe | |
| DE60045324D1 (de) | Impfstoffzusammensetzung | |
| DK0922386T3 (da) | Sammensætninger med reguleret frigivelse | |
| FR12C0010I2 (fr) | Composition herbicide | |
| NO20023672L (no) | Sammensetninger for kontrollert frigivelse | |
| AR023440A1 (es) | Composiciones antitranspirantes | |
| AR027907A1 (es) | Composicion de liberacion controlada | |
| ATE232364T1 (de) | Zuckergusszusammensetzung | |
| ID29785A (id) | Komposisi-komposisi sampo | |
| DE60103582D1 (de) | Zusammensetzungen mit kontrollierter Freisetzung | |
| ATE257691T1 (de) | Schweisshemmende zusammensetzungen | |
| DE69943245D1 (de) | Gaserzeugende zusammensetzung | |
| PT1158963E (pt) | Composicoes de libertacao controlada de beta-histina | |
| NO20021452D0 (no) | Orale kontrollerte frigivelsesformuleringer | |
| ATE297187T1 (de) | Resorcinenthaltende zusammensetzung | |
| DE60135023D1 (de) | Trennmittelzusammensetzung | |
| DE10080787D2 (de) | Mikrobiozide Zusammensetzung | |
| ID27329A (id) | Komposisi penghambat | |
| NO20022845L (no) | Limsammensetning | |
| DE60029780D1 (de) | Biozide zusammensetzungen | |
| DE60020836D1 (de) | Flammhemmende zusammensetzungen | |
| FI19992584A (fi) | Voidemainen koostumus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1218889 Country of ref document: EP |